Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matsuda

Showing results (661-670 of 706) with videos related to

Pageof 71
Sort By:
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial]Y Takahashi, M Kuriyama, S Yamada, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)N Asou, K Adachi, U Tamura, et al.
Scandinavian Journal of Rheumatology|September 13, 2021
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort studyY Nakayama, M Hashimoto, R Watanabe, et al.
Scandinavian Journal of Rheumatology|June 19, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort studyK Murata, T Fujii, K Ebina, et al.
Journal of Gastroenterology|June 1, 1996
Therapeutic effect of secretin in patients with jaundice; double-blind placebo-controlled multicentric trialY Fukumoto, K Okita, T Kodama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study GroupN Asou, K Adachi, J Tamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled studyR Ohno, S Miyawaki, K Hatake, et al.
Geophysical Research Letters|October 17, 2022
Quantifying the Size and Duration of a Microburst-Producing Chorus Region on 5 December 2017S S Elliott, A W Breneman, C Colpitts, et al.
The Japanese Journal of Antibiotics|June 15, 1999
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). III Secular changes in susceptibility]M Ogiwara, K Ishibashi, H Yoshida, et al.
Pageof 71

Showing results (661-670 of 706) with videos related to

Sort By:
Pageof 71
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[Clinical efficacy of post-TUR prophylactic chemotherapy for superficial bladder cancer--the result of co-operative prospective randomized trial]Y Takahashi, M Kuriyama, S Yamada, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)N Asou, K Adachi, U Tamura, et al.
Scandinavian Journal of Rheumatology|September 13, 2021
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort studyY Nakayama, M Hashimoto, R Watanabe, et al.
Scandinavian Journal of Rheumatology|June 19, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort studyK Murata, T Fujii, K Ebina, et al.
Journal of Gastroenterology|June 1, 1996
Therapeutic effect of secretin in patients with jaundice; double-blind placebo-controlled multicentric trialY Fukumoto, K Okita, T Kodama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study GroupN Asou, K Adachi, J Tamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled studyR Ohno, S Miyawaki, K Hatake, et al.
Geophysical Research Letters|October 17, 2022
Quantifying the Size and Duration of a Microburst-Producing Chorus Region on 5 December 2017S S Elliott, A W Breneman, C Colpitts, et al.
The Japanese Journal of Antibiotics|June 15, 1999
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). III Secular changes in susceptibility]M Ogiwara, K Ishibashi, H Yoshida, et al.
Pageof 71